24 samples
Export
<<< of 2>>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterGSE245782
GSM7848948
thioridazine-treated, small group, sample 1
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848949
thioridazine-treated, small group, sample 2
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848950
thioridazine-treated, small group, sample 3
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848951
thioridazine-treated, large group, sample 1
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848952
thioridazine-treated, large group, sample 2
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848953
thioridazine-treated, large group, sample 3
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848954
control, small group, sample 1
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848955
control, small group, sample 2
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848956
control, small group, sample 3
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848957
control, large group, sample 1
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848958
control, large group, sample 2
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848959
control, large group, sample 3
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848960
thioridazine-treated, small group, stage 35, sample 1
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848961
thioridazine-treated, small group, stage 35, sample 2
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848962
thioridazine-treated, small group, stage 35, sample 3
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848963
control, small group, stage 35, sample 1
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848964
control, small group, stage 35, sample 2
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848965
control, small group, stage 35, sample 3
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848966
thioridazine-treated, large group, stage 35, sample 1
SRA 1 Megan M Sperry Dec 02, 2023
GSM7848967
thioridazine-treated, large group, stage 35, sample 2
SRA 1 Megan M Sperry Dec 02, 2023